Correspondence 0001013762-24-001490 from Silo Pharma, Inc. (SILO)
Silo Pharma, Inc.
Date: July 26, 2024 · CIK: 0001514183 · Accession: 0001013762-24-001490
AI Filing Summary & Sentiment
Reasoning
Letter
Silo Pharma, Inc.
677 N. Washington Boulevard
Sarasota, FL 34236
July 26, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Patrick Fullem
Re: Silo Pharma, Inc. Registration Statement on Form S-1
File No. 333- 280855
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Silo Pharma, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Daylight Time, on Tuesday, July 30, 2024, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Please notify Greg Carney of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (213) 617-4209 as soon as possible as to the time the registration statement has been declared effective pursuant to this acceleration request.
Very truly yours,
SILO PHARMA, INC.
Show Raw Text
CORRESP
1
filename1.htm
Silo Pharma, Inc.
677 N. Washington
Boulevard
Sarasota, FL 34236
July 26, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Patrick Fullem
Re: Silo Pharma, Inc.
Registration Statement on Form S-1
File No. 333- 280855
Ladies and Gentlemen:
Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Silo Pharma, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 5:00 p.m., Eastern Daylight Time, on Tuesday, July 30, 2024, or as soon thereafter as possible. In
making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Please notify Greg Carney of Sheppard
Mullin Richter & Hampton LLP, counsel to the Company, at (213) 617-4209 as soon as possible as to the time the registration statement
has been declared effective pursuant to this acceleration request.
Very truly yours,
SILO PHARMA, INC.
By:
/s/ Eric Weisblum
Name:
Eric Weisblum
Title:
Chief Executive Officer
cc: Greg Carney, Sheppard Mullin Richter & Hampton LLP